Heat Biologics, Inc. (NASDAQ:HTBX) went up by 23.21% from its latest closing price compared to the recent 1-year high of $4.30. The company’s stock price has collected 15.00% of gains in the last five trading sessions.
Is It Worth Investing in Heat Biologics, Inc. (NASDAQ :HTBX) Right Now?
Heat Biologics, Inc. (NASDAQ:HTBX) scored a price-to-earnings ratio above its average ratio, recording 441.86 x from its present earnings ratio. Plus, the 36-month beta value for HTBX is at 0.46. Opinions of the stock are interesting as 3 analysts out of 3 who provided ratings for Heat Biologics, Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $4.63, which is -$1.38 below the current price. HTBX currently public float of 75.53M and currently shorts hold a 10.36% ratio of that float. Today, the average trading volume of HTBX was 31.80M shares.
HTBX’s Market Performance
HTBX stocks went up by 15.00% for the week, with a monthly drop of -17.86% and a quarterly performance of 86.46%, while its annual performance rate touched 129.58%. The volatility ratio for the week stands at 12.17% while the volatility levels for the past 30 days are set at 12.76% for Heat Biologics, Inc.. The simple moving average for the period of the last 20 days is 10.31% for HTBX stocks with a simple moving average of 64.66% for the last 200 days.
Analysts’ Opinion of HTBX
Noble Financial, on the other hand, stated in their research note that they expect to see HTBX reach a price target of $16. The rating they have provided for HTBX stocks is “Buy” according to the report published on January 8th, 2016.
H.C. Wainwright gave a rating of “Buy” to HTBX, setting the target price at $13 in the report published on May 26th of the previous year.
HTBX Trading at -18.29% from the 50-Day Moving Average
After a stumble in the market that brought HTBX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -67.91% of loss for the given period.
Volatility was left at 12.76%, however, over the last 30 days, the volatility rate increased by 12.17%, as shares sank -13.21% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +54.69% upper at present.
During the last 5 trading sessions, HTBX rose by +15.00%, which changed the moving average for the period of 200-days by +187.50% in comparison to the 20-day moving average, which settled at $1.2405. In addition, Heat Biologics, Inc. saw 190.53% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for HTBX
Current profitability levels for the company are sitting at:
- -636.11 for the present operating margin
The net margin for Heat Biologics, Inc. stands at -656.51. The total capital return value is set at -85.58, while invested capital returns managed to touch -87.94. Equity return is now at value -77.30, with -55.40 for asset returns.
Based on Heat Biologics, Inc. (HTBX), the company’s capital structure generated 14.21 points at debt to equity in total, while total debt to capital is 12.44.
When we switch over and look at the enterprise to sales, we see a ratio of 0.84, with the company’s debt to enterprise value settled at 0.75. The receivables turnover for the company is 96.00 and the total asset turnover is 0.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.80.